UA98631C2 - Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина) - Google Patents

Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина)

Info

Publication number
UA98631C2
UA98631C2 UAA200906998A UAA200906998A UA98631C2 UA 98631 C2 UA98631 C2 UA 98631C2 UA A200906998 A UAA200906998 A UA A200906998A UA A200906998 A UAA200906998 A UA A200906998A UA 98631 C2 UA98631 C2 UA 98631C2
Authority
UA
Ukraine
Prior art keywords
naphtyloxy
thienyl
purification
formula
methy
Prior art date
Application number
UAA200906998A
Other languages
English (en)
Ukrainian (uk)
Inventor
Людек Ридван
Йозеф Синибулк
Моника Затопкова
Лукас Пласек
Original Assignee
Зентива, К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39366525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA98631(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Зентива, К.С. filed Critical Зентива, К.С.
Publication of UA98631C2 publication Critical patent/UA98631C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Способ очистки (S)-N-метил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина гидрохлорида формулы I, который включает(a) преобразование вещества формулы I в ее свободное основание под действием органического или неорганического основания в водной среде; и(b) преобразование основания вещества формулы I в кристаллический гидрохлорид под действием хлороводородной кислоты или газообразной Hcl в органическом растворителе или смеси органических растворителей.Способ очиски (S)-N-метил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина гидрохлорида формулы I, который включает растворение этого вещества в минимальном количестве метанола, который содержит от 0 до 50 % воды, и ее преобразование назад в твердую фазу (осаждение) путем добавления менее полярного растворителя.(I)
UAA200906998A 2006-12-05 2007-12-05 Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина) UA98631C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20060773A CZ300116B6 (cs) 2006-12-05 2006-12-05 Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu

Publications (1)

Publication Number Publication Date
UA98631C2 true UA98631C2 (ru) 2012-06-11

Family

ID=39366525

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200906998A UA98631C2 (ru) 2006-12-05 2007-12-05 Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина)

Country Status (6)

Country Link
US (1) US20100069649A1 (ru)
EP (1) EP2089375B1 (ru)
CZ (1) CZ300116B6 (ru)
EA (1) EA017168B1 (ru)
UA (1) UA98631C2 (ru)
WO (1) WO2008067781A2 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4177C1 (ru) * 2011-01-14 2013-02-28 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Метод вакцинации против гепатита В лиц с иммунодефицитом

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110150942A1 (en) * 2008-06-13 2011-06-23 Natalija Zajc Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
CZ304602B6 (cs) * 2009-09-02 2014-07-30 Zentiva, K. S. Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu)
JP2016222628A (ja) * 2015-06-03 2016-12-28 株式会社トクヤマ デュロキセチン塩酸塩の製造方法
CN113429380B (zh) * 2021-07-14 2022-07-01 新发药业有限公司 一种度洛西汀的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL27173A (en) * 1966-01-12 1972-08-30 Sumitomo Chemical Co 1-carboxylic acyl-3-indolyl alkanoic acid derivatives and method for their preparation
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
GB0410470D0 (en) * 2004-05-11 2004-06-16 Cipla Ltd Pharmaceutical compound and polymorphs thereof
CZ297555B6 (cs) * 2004-10-26 2007-02-07 Zentiva, A. S. Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu)
WO2006099433A1 (en) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Pure duloxetine hydrochloride

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4177C1 (ru) * 2011-01-14 2013-02-28 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Метод вакцинации против гепатита В лиц с иммунодефицитом

Also Published As

Publication number Publication date
EA200900708A1 (ru) 2009-12-30
US20100069649A1 (en) 2010-03-18
CZ2006773A3 (cs) 2008-06-18
EP2089375A2 (en) 2009-08-19
WO2008067781A3 (en) 2008-07-24
CZ300116B6 (cs) 2009-02-11
EP2089375B1 (en) 2013-07-31
WO2008067781A2 (en) 2008-06-12
WO2008067781B1 (en) 2008-10-02
EA017168B1 (ru) 2012-10-30

Similar Documents

Publication Publication Date Title
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
UA98631C2 (ru) Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина)
NO330968B1 (no) Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
TW200616994A (en) Novel thiophene derivatives
WO2007011820A3 (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
HRP20110425T1 (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
NO20074005L (no) Antisugvaeske til bruk i underjordiske formasjoner
RS51943B (en) PIPERIDINSKI GPCR AGONIST
RS52168B (en) PIPERIDINSKI GPCR AGONIST
TW200728455A (en) PH buffered aqueous cleaning composition and method for removing photoresist residue
EA200700888A1 (ru) Способ получения (s)-n-метил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина гидрохлорида (дулоксетина)
EA200701676A1 (ru) Производные дигидроимидазотиазола
NO20034236L (no) Ny fremgangsmate for den industrielle syntese av tetraestere av 5-[bis(karboksymetyl)amino]-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater
TW200627095A (en) Remover composition
CY1108804T1 (el) Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
EA200600878A1 (ru) Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
WO2007014683A3 (de) Chromfreie, zinkarme, korrosionshemmende pigmentmischung, verfahren zu ihrer herstellung und ihre verwendung
WO2008068423A3 (fr) Derives de pyrrole, leur preparation et leur utilisation en therapeutique.
DK2084198T3 (da) Beklædningssammensætning
WO2009019719A3 (en) Process for the preparation of 3-aryloxy-3-arylpropanamines
EA200601563A1 (ru) Водно-изопропанольный сольват оланзапина
BR0307671A (pt) Derivados de tricicloimidazolina, método para sua produção e uso dos mesmos como medicamentos
JP2004200718A5 (ru)
TH79586B (th) สารประกอบอินทรีย์
JP2006028125A5 (ru)